MRNA
Moderna Inc
187.50$
-7.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -87.4% | 22.1% | -592.2% | -576.5% | -84.4% | 86.3% | -969.2% | -647.2% | -83.4% | 140.3% | -162.0% | -362.8% | -47.2% | |
| 13.6% | 7.2% | 21.6% | 18.6% | 2.8% | 6.3% | 36.4% | 40.1% | 5.1% | 9.9% | 15.2% | 43.4% | 10.8% | |
| 4.2% | 2.8% | 60.5% | 50.7% | 6.0% | 10.9% | 107.5% | 91.5% | 12.3% | 16.7% | 26.7% | 82.8% | 20.7% | |
| 87.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 9.9% | 8.9% | 35.9% | -66.1% | 4.6% | 181.7% | -197.2% | -209.2% | -80.5% | 233.0% | 142.2% | -12.4% | 58.2% | |
| 7.6% | 7.8% | 117.4% | 82.4% | 8.1% | 54.6% | 118.7% | 2.1% | 3.2% | 5.8% | 15.9% | 25.5% | 7.7% | |
| 43.1% | -19.1% | 70.7% | 746.2% | 38.9% | -56.4% | 682.2% | 397.2% | 68.9% | -7.1% | -19.5% | 226.9% | 40.6% | |
| 3.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | -1.4% | – | |
| -3.5% | – | – | – | 0.2% | -1.5% | 1.9% | -3.5% | -0.3% | 83.5% | 0.0% | -4.8% | 25.0% | |
| -3.2% | -3.9% | 8.4% | 15.4% | 0.6% | -0.3% | 3.7% | 6.3% | -0.1% | 82.6% | 4.4% | 9.7% | 26.5% | |
| -47.5% | -0.9% | -513.2% | 185.1% | -44.9% | 29.5% | -283.2% | -243.0% | -14.5% | 215.6% | -176.9% | -127.6% | 19.8% | |
| -95.0% | 14.3% | -709.6% | -658.8% | -92.6% | 31.7% | -1,087.9% | -649.3% | -86.6% | 134.5% | -177.9% | -388.3% | -54.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.